methyl 4-[(2-chlorophenothiazin-10-yl)methyl]benzoate

ID: ALA5180453

Chembl Id: CHEMBL5180453

PubChem CID: 131953895

Max Phase: Preclinical

Molecular Formula: C21H16ClNO2S

Molecular Weight: 381.88

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc(CN2c3ccccc3Sc3ccc(Cl)cc32)cc1

Standard InChI:  InChI=1S/C21H16ClNO2S/c1-25-21(24)15-8-6-14(7-9-15)13-23-17-4-2-3-5-19(17)26-20-11-10-16(22)12-18(20)23/h2-12H,13H2,1H3

Standard InChI Key:  HIDDWKTVRSKQSL-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5180453

    ---

Associated Targets(Human)

PSMB2 Tclin 20S proteasome (530 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 381.88Molecular Weight (Monoisotopic): 381.0590AlogP: 5.93#Rotatable Bonds: 3
Polar Surface Area: 29.54Molecular Species: HBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.18CX LogD: 6.18
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.53Np Likeness Score: -1.21

References

1. Staerz SD, Jones CL, Tepe JJ..  (2022)  Design, Synthesis, and Biological Evaluation of Potent 20S Proteasome Activators for the Potential Treatment of α-Synucleinopathies.,  65  (9.0): [PMID:35476454] [10.1021/acs.jmedchem.1c02158]

Source